Trials / Recruiting
RecruitingNCT01280825
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Conditions
- Patients Undergoing Routine Health Care
- Heart Diseases
- Inflammatory Bowel Diseases
- Autoimmune Disease
- Inflammatory Disease
- Blood Coagulation Disorders
- Hepatitis C
- Non-Metastatic Neoplasm
Timeline
- Start date
- 2011-01-14
- Primary completion
- 2027-11-14
- Completion
- 2027-12-14
- First posted
- 2011-01-21
- Last updated
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01280825. Inclusion in this directory is not an endorsement.